Redeye stands behind its Enea case, as mentioned in our report note, despite a Corona-haunted Q3. We bet that Enea resolves the situation, as it has done every time before, and reiterate our valuation. Looking at any longer (1-year) period for the past decade, it has so far not paid off to bet against Enea.